Bayer, the inventor of
aspirin, is among the world's top 20 pharmaceutical groups,
with products including Yasmin birth - control pills and stroke
prevention drug Xarelto.
More than 10 percent of patients treated
with aspirin therapy for primary cardiovascular disease
prevention were likely inappropriately prescribed medication, according to a new study in the Journal of the American College of Cardiology that examined practice variations in
aspirin therapy.